← FDA Drug Approvals (Drugs@FDA)
RAMELTEON
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-11-25
Drug application
- FDA Application #
ANDA216209- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- RAMELTEON
- Generic name
- RAMELTEON
- Active ingredients
- RAMELTEON
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- Xiromed, LLC
- First approval
- 2022-11-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown